| 臺大學術典藏 |
2021-07-21T23:21:30Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; Huang, Yen Lin; CHONG-JEN YU; Chih-Hsin Yang, James; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-05T05:32:31Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung, Kuei-Pin; Huang, Yen-Lin; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang; Nakahira, Kiichi; Huang, Yen-Tsung; Lin, Mong-Wei; SHANG-GIN WU; Shih, Jin-Yuan; Chang, Yih-Leong; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-05-05T05:31:04Z |
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Shang-Gin Wu;Chiang, Chi-Lu;Liu, Chien-Ying;Wang, Chin-Chou;Su, Po-Lan;Hsia, Te-Chun;Shih, Jin-Yuan;Chang, Gee-Chen; SHANG-GIN WU; Chiang, Chi-Lu; Liu, Chien-Ying; Wang, Chin-Chou; Su, Po-Lan; Hsia, Te-Chun; Shih, Jin-Yuan; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-05-05T05:28:58Z |
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
|
Shang-Gin Wu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; SHANG-GIN WU; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2020-08-12T08:25:32Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
SHANG-GIN WU; Shih J.-Y.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:30Z |
Disseminated Cryptococcus neoformans var. grubii infections in intensive care units
|
Chuang Y.-M.; Ku S.C.; Liaw S.J.; SHANG-GIN WU; Ho Y.C.; Yu C.J.; Hsueh P.R. |
| 臺大學術典藏 |
2020-08-12T08:25:30Z |
Successful weaning after plasma exchange for polyneuropathy related to POEMS syndrome
|
SHANG-GIN WU; Kuo P.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:30Z |
Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection
|
Yang P.-C.; Kuo P.-H.; Wu J.-Y.; SHANG-GIN WU; Sun H.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:29Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H.; Tsai M.-F.; Su K.-Y.; SHANG-GIN WU; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:29Z |
Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis
|
Wu S.-J.; Tsai T.-H.; Shang-Gin Wu ;Tsai T.-H. ;Wu S.-J.; SHANG-GIN WU |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Pericardial pigtail knotting
|
Shang-Gin Wu ;Shih J.-Y.; SHANG-GIN WU; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Shang-Gin Wu ;Chang Y.-L. ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; SHANG-GIN WU; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:27Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
SHANG-GIN WU; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Shang-Gin Wu;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; SHANG-GIN WU; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Brain metastasis in NSCLC patients: Mechanism, diagnosis and treatment
|
Shih J.-Y.; SHANG-GIN WU; Shang-Gin Wu;Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:25Z |
Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy
|
Shih J.-Y.; SHANG-GIN WU |
| 臺大學術典藏 |
2020-08-12T08:25:25Z |
Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case
|
Gow C.-H.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:25Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
Treatment outcome of patients with isoniazid mono-resistant tuberculosis
|
Yu C.-J.; Chien J.-Y.; Chen Y.-T.; SHANG-GIN WU; Lee J.-J.; Wang J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; SHANG-GIN WU; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
SHANG-GIN WU; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.; Chen Y.-F.;Hsieh M.-S.;Shang-Gin Wu;Chang Y.-L.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Shih J.-Y.; Tsai M.-F.; Chang T.-H.; SHANG-GIN WU; Yang H.-Y.; Hsu Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai T.-H.;Shang-Gin Wu;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:22Z |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
SHANG-GIN WU; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Shang-Gin Wu;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; SHANG-GIN WU; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.; Hsieh M.-S.; SHANG-GIN WU; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:20Z |
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
|
Shang-Gin Wu;Shih J.-Y.; SHANG-GIN WU; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:19Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:18Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:17Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2019 |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Shih J.-Y.; Chang Y.-L.; Gow C.-H.; Tsai T.-H.; Chang T.-H.; Liu Y.-N.;Tsai M.-F.;Shang-Gin Wu;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; SHANG-GIN WU |
| 臺大學術典藏 |
2019 |
High throughput sequencing of T-cell receptor repertoire using dry blood spots
|
Li S.; SHANG-GIN WU; Pan W.; Liu H.; Byrne-Steele M.L.; Brown B.; Depinet M.; Hou X.; Han J. |
| 臺大學術典藏 |
2019 |
MicroRNA in lung cancer metastasis
|
Shang-Gin Wu;Chang T.-H.;Liu Y.-N.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Liu Y.-N.; Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
|
Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; SHANG-GIN WU; Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Shih J.-Y. |
| 臺大學術典藏 |
2016 |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
SHANG-GIN WU; Lin C.-H.; Cheng A.-L.; Lu Y.-S.; Shih J.-Y.; Yang J.C.-H.; Huang W.-C.; Wu P.-F. |
| 臺大學術典藏 |
2012 |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Chung K.-P.;Shang-Gin Wu;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; SHANG-GIN WU; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2012 |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.; SHANG-GIN WU; Su K.-Y.; Tsai T.-H. |
| 中國醫藥大學 |
2011-04 |
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
|
(Tzu-Hua Chan); (Meng-Feng Tsai); (Kang-Yi Su); (Shang-Gin Wu); (Cheng-Po Huang); (Sung-Liang Yu); 余永倫(Yung-Luen Yu); (Chou-Chin Lan); (Chih-Hsin Yang); (Shwu-Bin Lin); (Chin-Pyng Wu); (Jin-Yuan Shih); (Pan-Chyr Yang)* |
| 臺大學術典藏 |
2011 |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Shang-Gin Wu ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Chang Y.-L. ;Shih J.-Y. ;Yang P.-C.; SHANG-GIN WU; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2011 |
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
|
Yang P.-C.; Shih J.-Y.; Hsu Y.-C.; Chang Y.-C.; Chang Y.-L.; Yang C.-H.; SHANG-GIN WU; Wu J.-Y. |
| 臺大學術典藏 |
2010 |
Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
|
Kuo Y.-W.; SHANG-GIN WU; Ho C.-C.; Shih J.-Y. |
